Extranodal Nk T-cell Lymphoma
📧 Sign up to get email alerts when something new happens for Extranodal Nk T-cell Lymphoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2016-08-25Clinical Trial Update: Differences Between Chidamide Taken Daily and Twice a Week in Therapeutic Effect，Pharmacokinetics, Pharmacodynamics and EB Virus Activation [Phase 2]
Phase 2 trial comparing daily versus twice-weekly dosing of chidamide and evaluating differences in therapeutic effect, pharmacokinetics/pha…
-
CLINICAL_TRIALS trial_result · 2016-01-21Clinical Trial Update: Campath-1H and EPOCH to Treat Non-Hodgkin's T- and NK-Cell Lymphomas [Phase 2]
Phase 2 clinical trial update evaluating Campath-1H with EPOCH for T-cell and NK/T-cell lymphomas has completed; results posted.
-
CLINICAL_TRIALS trial_result · 2015-07-02Clinical Trial Update: Dasatinib in Treating Patients With Solid Tumors or Lymphomas That Are Metastatic or Cannot Be Removed By Surgery [Phase 1]
Phase 1 study sponsored by the National Cancer Institute evaluating dasatinib in patients with metastatic or unresectable solid tumors and l…
-
CLINICAL_TRIALS research · 2013-12-24Clinical Trial Update: MESA Treatment for NK/T Cell Lymphoma [Phase 2]
A Phase 2 clinical trial is exploring the MESA treatment regimen for extranodal NK/T-cell lymphoma, with the current trial status listed as …
-
CLINICAL_TRIALS trial_result · 2013-07-31Clinical Trial Update: A Pilot Study of Romidepsin in Relapsed or Refractory Extranodal NK/T-cell Lymphoma [EARLY_Phase 1]
An early-phase 1 pilot study evaluated romidepsin in relapsed or refractory extranodal NK/T-cell lymphoma and has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2012-08-07Clinical Trial Update: Retrospective Analysis of Skin/Soft Tissue Primary NK/T Cell Lymphoma
This document reports a retrospective analysis of patients with skin/soft tissue primary Extranodal NK/T-cell lymphoma. It summarizes outcom…
-
CLINICAL_TRIALS research · 2012-05-07Clinical Trial Update: Immunotherapy in Peripheral T Cell Lymphoma - the Role of Alemtuzumab in Addition to Dose Dense CHOP [Phase 3]
A Phase 3 clinical trial evaluating adding alemtuzumab to dose-dense CHOP for peripheral T-cell lymphomas, including angioimmunoblastic T-ce…